MARKET

MIRM

MIRM

Mirum Pharmaceuticals
NASDAQ
123.77
+6.49
+5.53%
After Hours: 122.44 -1.33 -1.07% 18:13 06/26 EDT
OPEN
116.51
PREV CLOSE
117.28
HIGH
124.44
LOW
113.41
VOLUME
3.37M
TURNOVER
--
52 WEEK HIGH
124.44
52 WEEK LOW
47.89
MARKET CAP
7.55B
P/E (TTM)
-9.0977
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at MIRM last week (0615-0619)?
Weekly Report · 6d ago
Mirum SVP, Global Controller Jolanda Howe sells 2,594 shares for $264,458.3
PUBT · 06/18 22:40
Mirum Shareholders Approve Directors, Auditors and Compensation
TipRanks · 06/18 21:01
Mirum Pharmaceuticals holds annual shareholder meeting
PUBT · 06/18 20:06
MIRM, INCY Report Positive Rare Disease Data as FDA Begins NDA Review (Revised)
NASDAQ · 06/17 10:47
MIRM, INCY Report Positive Rare Disease Data as FDA Begins NDA Review (Revised)
NASDAQ · 06/16 07:55
Mirum Pharmaceuticals Is Maintained at Market Outperform by Citizens
Dow Jones · 06/15 14:16
Citizens Maintains Market Outperform on Mirum Pharmaceuticals, Raises Price Target to $146
Benzinga · 06/15 14:06
More
About MIRM
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the treatment of rare diseases affecting children and adults. It has three medicines: LIVMARLI (maralixibat) oral solution (Livmarli), Cholbam (cholic acid) capsules, and Chenodal or Ctexli (chenodiol) tablets. Livmarli is an orally administered, minimally-absorbed ileal bile acid transporter (IBAT) inhibitor (IBATi) that is used for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS) in the United States and various other countries and for cholestatic pruritus in patient with progressive familial intrahepatic cholestasis (PFIC) in the United States, Canada and Japan. Cholbam is used for the treatment of bile acid synthesis disorders due to single enzyme deficiencies and adjunctive treatment of peroxisomal disorders. The Company is also advancing its product candidate, volixibat, for the treatment of adult patients with cholestatic liver diseases.

Webull offers Mirum Pharmaceuticals Inc stock information, including NASDAQ: MIRM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MIRM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MIRM stock methods without spending real money on the virtual paper trading platform.